What do systematic reviews say?

Continuous positive airway pressure (CPAP) vs sham CPAP

• Non‐invasive positive airway pressure therapy for improving erectile dysfunction in men with obstructive sleep apnoea 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 61 participants
  GRADE not reported

Intervention not reported

• Magnetic seizure therapy for treatment‐resistant depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 20 participants
  Very low

Intervention not reported

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported

Intervention not reported

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported

Intervention not reported

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported

Intervention not reported

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported

Intervention not reported

• High‐dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin… 2013 · Cochrane Headline outcomes only
  no estimate extracted
  0 studies · 0 participants
  GRADE not reported

Respite care vs polarity therapy

The review found no eligible studies for this question.

• Respite care for people with dementia and their carers 2014 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Surgery vs Pharmacological therapy

Surgery alone showed no clear difference in health‐related quality of life Mean AcroQoL score (0‐100) compared with pharmacological therapy alone (low certainty).

• Surgical and non‐surgical interventions for primary and salvage treatment of growth hormone‐secreting pituitary… 2024 · Cochrane Headline outcomes only
  MD 10
  1 study · 22 participants
  Low

Summary of findings table ‐ Cognitive rehabilitation vs inactive control

• Cognitive rehabilitation for people with mild to moderate dementia 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 464 participants
  Moderate

Double‐dose adenovirus‐thymidine kinase with ganciclovir (ADV‐TK/GCV) plus liver transplantation vs liver transplantation

The review found no eligible studies for this question.

• Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Recombinant human adenovirus‐p53 and hydroxycamptothecin (rAd‐p53/HCT) vs hydroxycamptothecin

The review found no eligible studies for this question.

• Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Recombinant human adenovirus‐p53 and 5‐fluorouracil (rAd‐p53/5‐Fu) plus transarterial chemoembolisation vs chemoembolisation

The review found no eligible studies for this question.

• Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

E1B‐deleted (dl1520) adenovirus vs percutaneous alcohol injection

The review found no eligible studies for this question.

• Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Pexastimogene devacirepvec (Pexa‐Vec) plus best supportive care vs best supportive care

• Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 129 participants
  Very low

Adenovirus‐thymidine kinase with ganciclovir (ADV‐TK/GCV) plus liver transplantation vs liver transplantation

The review found no eligible studies for this question.

• Gene therapy for people with hepatocellular carcinoma 2024 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs usual pharmacological care alone

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs another intervention (education, joint aids, or relaxation) plus usual pharmacological care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Exercise plus usual pharmacological care vs placebo + standard care

The review found no eligible studies for this question.

• Exercise as adjunctive therapy for systemic lupus erythematosus 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

175 mg/m2 paclitaxel vs 250 mg/m2 paclitaxel

The review found no eligible studies for this question.

• Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found